Trump tariffs will loom over financial markets in 2025 but may not be as nasty as the president-elect previously flagged.

Dual-listed regenerative medicine company Avita Medical has seen its share price slide ~19% today on a downgrade of its ...

The ASX keeps charging, while Wall Street slips on strong US data and Energy Transition Minerals pops on Trump's Greenland ...

Australian Mines (ASX:AUZ) is exploring potential production scenarios after nearly doubling its scandium resource in NSW.

Aubiotech hopes to score some quick runs with a pre-budget submission on ways to fix the sector's "stubborn issues" ...

After the benchmark S&P/ASX 200 surged 7.5 per cent in 2024, investors are looking to see where the growth will come from in ...